Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

773

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

NVA237 50µg once daily

NVA237 50 μg o.d., delivered via single-dose dry-powder inhaler (SDDPI)

DRUG

Tiotropium 18µg once daily

Tiotropium 18 μg o.d. delivered via a proprietary inhalation device

DRUG

Flu/Sal

Flu/Sal 500/50 μg b.i.d. delivered via a proprietary inhalation device

DRUG

NVA237 placebo + Tiotropium placebo.

Tiotropium 18 μg o.d. delivered via a proprietary inhalation device

Trial Locations (71)

1010

Novartis Investigative Site, Grafton, Auckland

1051

Novartis Investigative Site, Auckland

2010

Novartis Investigative Site, Darlinghurst

2067

Novartis Investigative Site, Castle Hill

2089

Novartis Investigative Site, Sydney

2100

Novartis Investigative Site, Brookvale

2153

Novartis Investigative Site, Baulkham Hills

2168

Novartis Investigative Site, Hinchinbrook

2250

Novartis Investigative Site, Gosford

2747

Novartis Investigative Site, Kingswood

3063

Novartis Investigative Site, Rosebud

3075

Novartis Investigative Site, Lalor

3143

Novartis Investigative Site, Tauranga

3144

Novartis Investigative Site, Malvern

3166

Novartis Investigative Site, Oakleigh East

3174

Novartis Investigative Site, Noble Park

3240

Novartis Investigative Site, Hamilton

4021

Novartis Investigative Site, Kippa-Ring

4032

Novartis Investigative Site, Chemside

Novartis Investigative Site, Jimboomba

4034

Novartis Investigative Site, Aspley

4053

Novartis Investigative Site, Everton Plaza

4069

Novartis Investigative Site, Kenmore

4102

Novartis Investigative Site, Woolloongabba

4114

Novartis Investigative Site, Logan Central

4118

Novartis Investigative Site, Browns Plains

4121

Novartis Investigative Site, Holland Park

4129

Novartis Investigative Site, Loganholme

4207

Novartis Investigative Site, Beenleigh

4211

Novartis Investigative Site, Nerang

4214

Novartis Investigative Site, Arundel

4218

Novartis Investigative Site, Mermaid Beach

4506

Novartis Investigative Site, Morayfield

4508

Novartis Investigative Site, Deception Bay

5000

Novartis Investigative Site, Adelaide

5041

Novartis Investigative Site, Daw Park

5045

Novartis Investigative Site, Glenelg East

5065

Novartis Investigative Site, Kensington Gardens

5082

Novartis Investigative Site, Prospect

5125

Novartis Investigative Site, Golden Grove

5401

Novartis Investigative Site, Hamley Bridge

6000

Novartis Investigative Site, Perth

6009

Novartis Investigative Site, Nedlands

6021

Novartis Investigative Site, Wellington

6026

Novartis Investigative Site, Woodvale

6060

Novartis Investigative Site, Yokine

6061

Novartis Investigative Site, Mirrabooka

6062

Novartis Investigative Site, Morley

6069

Novartis Investigative Site, Perth

6101

Novartis Investigative Site, East Victoria Park

6158

Novartis Investigative Site, East Fremantle

6160

Novartis Investigative Site, Fremantle

6163

Novartis Investigative Site, Spearwood

Unknown

Novartis Investigative Site, Dapto

Novartis Investigative Site, Ermington

Novartis Investigative Site, Kedron

Novartis Investigative Site, Dandenong

Novartis Investigative Site, Melbourne

Novartis Investigative Site, Preston

Novartis Investigative Site, Bicton

Novartis Investigative Site, Noranda

Novartis Investigative Site, Perth

Novartis Investigative Site, Pinjarra

Novartis Investigative Site, Auckland

Novartis Investigative Site, Christchurch

Novartis Investigative Site, Tauranga

Novartis Investigative Site, Tauranga

Novartis Investigative Site, Wellington

Novartis Investigative Site, Auckland

Novartis Investigative Site, Christchurch

Novartis Investigative Site, Dunedin

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY